Mechanism of Beraprost Effects on Pulmonary Hypertension: Contribution of Cross-Binding to PGE2 Receptor 4 and Modulation of O2 Sensitive Voltage-Gated K+ Channels

Background: The purpose of this study is to elucidate mechanism(s) by which the orally active PGI2 analog, Beraprost (BPS), ameliorates pulmonary hypertension (PH). Prostaglandins are an important treatment for PH. Mechanisms of their action are not fully elucidated in relation to receptor subtype a...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Fenling Fan, Hua Tian, Jie Geng, Jizhao Deng, Ya Liu, Chunyan Chen, Songlin Zhang, Yushun Zhang, Jie Li, Hongyan Tian, Anthony M. Dart, Yuliang Zou
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2019-01-01
Серии:Frontiers in Pharmacology
Предметы:
pulmonary arterial hypertension
prostanoids
Beraprost
IP receptor
EP4 receptor
Kv channel
Online-ссылка:https://www.frontiersin.org/article/10.3389/fphar.2018.01518/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы